Strong Support

Men between 55 and 67 who take testosterone therapy may be almost half as likely to die from prostate cancer as men who don’t take it, based on a long-term study.

53
Pro
0
Against

Evidence from Studies

Supporting (1)

53

Community contributions welcome

This study found that men taking testosterone therapy were less likely to die from prostate cancer than those who didn’t take it — exactly what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.